These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14502484)

  • 1. Multilinear regression and comparative molecular field analysis (CoMFA) of azo dye-fiber affinities. 2. Inclusion of solution-phase molecular orbital descriptors.
    Schüürmann G; Funar-Timofei S
    J Chem Inf Comput Sci; 2003; 43(5):1502-12. PubMed ID: 14502484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative molecular field analysis (CoMFA) of anionic azo dye-fiber affinities I: gas-phase molecular orbital descriptors.
    Funar-Timofei S; Schüürmann G
    J Chem Inf Comput Sci; 2002; 42(4):788-95. PubMed ID: 12132879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative molecular surface analysis (CoMSA) for modeling dye-fiber affinities of the azo and anthraquinone dyes.
    Polanski J; Gieleciak R; Wyszomirski M
    J Chem Inf Comput Sci; 2003; 43(6):1754-62. PubMed ID: 14632421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steric and electrostatic effects in dye-cellulose interactions by the MTD and CoMFA approaches.
    Timofeir S; Kurunczi L; Schmidt W; Simon Z
    SAR QSAR Environ Res; 2002 Mar; 13(2):219-26. PubMed ID: 12071650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR comparative molecular field analysis on delta opioid receptor agonist SNC80 and its analogs.
    Peng Y; Keenan SM; Zhang Q; Welsh WJ
    J Mol Graph Model; 2005 Sep; 24(1):25-33. PubMed ID: 15950508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial charge calculation method affects CoMFA QSAR prediction accuracy.
    Mittal RR; Harris L; McKinnon RA; Sorich MJ
    J Chem Inf Model; 2009 Mar; 49(3):704-9. PubMed ID: 19239274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSPR study of absorption maxima of organic dyes for dye-sensitized solar cells based on 3D descriptors.
    Xu J; Zhang H; Wang L; Liang G; Wang L; Shen X; Xu W
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Jul; 76(2):239-47. PubMed ID: 20381412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional QSAR analyses of 1,3,4-trisubstituted pyrrolidine-based CCR5 receptor inhibitors.
    Zhuo Y; Kong R; Cong XJ; Chen WZ; Wang CX
    Eur J Med Chem; 2008 Dec; 43(12):2724-34. PubMed ID: 18538451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the antitumor activity of novel tricyclicpiperazinyl derivatives as farnesyltransferase inhibitors using CoMFA and CoMSIA.
    Puntambekar DS; Giridhar R; Yadav MR
    Eur J Med Chem; 2006 Nov; 41(11):1279-92. PubMed ID: 16919851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies.
    Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK
    J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach.
    Puntambekar D; Giridhar R; Yadav MR
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1821-7. PubMed ID: 16455255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
    Akula N; Lecanu L; Greeson J; Papadopoulos V
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional quantitative structure: activity relationship studies on diverse structural classes of HIV-1 integrase inhibitors using CoMFA and CoMSIA.
    Nunthaboot N; Tonmunphean S; Parasuk V; Wolschann P; Kokpol S
    Eur J Med Chem; 2006 Dec; 41(12):1359-72. PubMed ID: 17002889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative molecular field analysis (CoMFA) study using semiempirical, density functional, ab initio methods and pharmacophore derivation using DISCOtech on sigma 1 ligands.
    Jung D; Floyd J; Gund TM
    J Comput Chem; 2004 Aug; 25(11):1385-99. PubMed ID: 15185333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CoMFA modeling of human catechol O-methyltransferase enzyme kinetics.
    Sipilä J; Taskinen J
    J Chem Inf Comput Sci; 2004; 44(1):97-104. PubMed ID: 14741015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-QSAR studies on the inhibitors of AP-1 and NF-kappaB mediated transcriptional activation.
    Qin J; Liu H; Li J; Ren Y; Yao X; Liu M
    Eur J Med Chem; 2009 Jul; 44(7):2888-95. PubMed ID: 19128859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the intrinsic hydrogen bond acceptor strength of organic compounds by local molecular parameters.
    Schwöbel J; Ebert RU; Kühne R; Schüürmann G
    J Chem Inf Model; 2009 Apr; 49(4):956-62. PubMed ID: 19296715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
    Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
    Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor.
    Sharma RN; Thakar H; Vasu KK; Chaturvedi SC
    Acta Pharm; 2008 Sep; 58(3):335-45. PubMed ID: 19103570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.